N2OFF INC (NITO)

US80512Q4029 - Common Stock

0.213  +0 (+1.48%)

After market: 0.2073 -0.01 (-2.68%)

Fundamental Rating

2

NITO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. NITO has a great financial health rating, but its profitability evaluates not so good. NITO does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

NITO had negative earnings in the past year.
In the past year NITO has reported a negative cash flow from operations.
In the past 5 years NITO always reported negative net income.
In the past 5 years NITO always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -75.62%, NITO is not doing good in the industry: 96.47% of the companies in the same industry are doing better.
With a Return On Equity value of -94.70%, NITO is not doing good in the industry: 91.76% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -75.62%
ROE -94.7%
ROIC N/A
ROA(3y)-80.63%
ROA(5y)-154.16%
ROE(3y)-91.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 88.74%, NITO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of NITO has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for NITO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 88.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.46%
GM growth 5Y1.22%

7

2. Health

2.1 Basic Checks

NITO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NITO has more shares outstanding
NITO has more shares outstanding than it did 5 years ago.
NITO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -7.17, we must say that NITO is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.17, NITO is doing worse than 84.71% of the companies in the same industry.
NITO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.17
ROIC/WACCN/A
WACC9.07%

2.3 Liquidity

NITO has a Current Ratio of 3.43. This indicates that NITO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.43, NITO belongs to the top of the industry, outperforming 85.88% of the companies in the same industry.
A Quick Ratio of 3.37 indicates that NITO has no problem at all paying its short term obligations.
NITO's Quick ratio of 3.37 is amongst the best of the industry. NITO outperforms 92.94% of its industry peers.
Industry RankSector Rank
Current Ratio 3.43
Quick Ratio 3.37

0

3. Growth

3.1 Past

NITO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.62%, which is quite impressive.
Looking at the last year, NITO shows a very negative growth in Revenue. The Revenue has decreased by -61.35% in the last year.
NITO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.33% yearly.
EPS 1Y (TTM)62.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.46%
Revenue 1Y (TTM)-61.35%
Revenue growth 3Y4.63%
Revenue growth 5Y-9.33%
Sales Q2Q%-58.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NITO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NITO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

N2OFF INC

NASDAQ:NITO (11/22/2024, 8:00:02 PM)

After market: 0.2073 -0.01 (-2.68%)

0.213

+0 (+1.48%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.43M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -75.62%
ROE -94.7%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 88.74%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.43
Quick Ratio 3.37
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)62.62%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-61.35%
Revenue growth 3Y4.63%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y